doi:10.3969/j.issn.1673-8640.2016.010.014

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 9

[1]	RICHTER SS,BEEKMANN SE,CROCO JL,et al.Minimizing the workup of blood culture contaminants:implementation and evaluation of a laboratory-based algorithm[J]. J Clin Microbiol,2002,40(7):2437-2444.
[2]	MARTIN GS,MANNINO DM,ESTON S,et al.The epidemiology of sepsis in the United States from 1979 through 2000[J]. N Engl J Med,2003,348(16):1546-1554.
[3]	罗淼,王昌明,曾锦荣,等. 发热患者血培养阳性率的多因素分析[J]. 临床合理用药杂志,2009,2(4):28-29.
[4]	SHAPIRO MF,GREENFIELD S.The complete blood count and leukocyte differential count. An approach to their rational application[J]. Ann Intern Med,1987,106(1):65-74.
[5]	SEEBACH JD,MORANT R,RUEGG R,et al.The diagnostic value of the neutrophil left shift in predicting inflammatory and infectious disease[J]. Am J Clin Pathol,1997,107(5):582-591.
[6]	LEIBOVICI L,GREENSHTAIN S,COHEN O,et al.Bacteremia infebrile patients. A clinical model for diagnosis[J]. Arch Intern Med,1991,151(9):1801-1806.
[7]	MCWILLIAM S,RIORDAN A.How to use:C-reactive protein[J]. Arch Dis Child Educ Pract Ed,2010,95(2):55-58.
[8]	钟倩怡,李招云,卢国光,等. 感染性标志物预测血流感染早期诊断价值的分析[J]. 检验医学,2015,30(5):522-524.
[9]	DE JAGER CP,VAN WIJK PT,MATHOERA RB,et al.Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit[J]. Crit Care,2010,14(5):R192.

组别	例数	CRP（mg/L）	NLR
血培养阳性组	49	61.8±51.7^*	14.06±10.6^*
正常对照组	20	2.3±1.8	6.8±2.5

组别	例数	CRP（mg/L）	NLR
血培养阳性组	49	61.8±51.7^*	14.06±10.6^*
正常对照组	20	2.3±1.8	6.8±2.5

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 9

Related Articles 15

Recommended Articles

Metrics